July 9, 2020 / 5:04 AM / a month ago

BRIEF-BioMerieux H1 Revenue Up 15.7% Organically At EUR 1.48 Bln

July 9 (Reuters) - BioMerieux SA:

* SECOND-QUARTER 2020 BUSINESS PERFORMANCE PREANNOUNCEMENT

* ORGANIC GROWTH OF 15.7% AT CONSTANT EXCHANGE RATES AND SCOPE OF CONSOLIDATION OVER FIRST HALF OF 2020: EUR 1,476 MILLION IN SALES

* AS EXPECTED, ADVERSE IMPACT OF GLOBAL HEALTH CRISIS ON MICROBIOLOGY, IMMUNOASSAY AND INDUSTRIAL APPLICATIONS PRODUCT LINES

* 2020 FINANCIAL OBJECTIVES REMAIN WITHDRAWN DUE TO A LACK OF VISIBILITY ON ALL CONSEQUENCES OF HEALTH CRISIS Source text for Eikon: Further company coverage: (Gdansk Newsroom)

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below